Glaxo and Genmab drop IV version of MS immune drug
Glaxo and Genmab drop IV version of MS immune drug
GlaxoSmithKline PLC and Genmab A/S will end the development of an intravenous form of a drug intended to treat autoimmune diseases like lupus and multiple sclerosis, and focus on an injectable version.
The companies said an injectable version of Arzerra (ofatumumab) should be more convenient for patients and have fewer side effects. The drug can also be used to treat rheumatoid arthritis...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1659 Views
-
Last post by goellerc
-
- 0 Replies
- 1115 Views
-
Last post by ElliotB
-
- 61 Replies
- 13355 Views
-
Last post by jimmylegs
-
- 3 Replies
- 4864 Views
-
Last post by NHE
-
- 5 Replies
- 13254 Views
-
Last post by gibbledygook
-
- 1 Replies
- 1493 Views
-
Last post by ElliotB
-
- 0 Replies
- 734 Views
-
Last post by DIM
-
- 0 Replies
- 463 Views
-
Last post by NHE
-
- 0 Replies
- 1423 Views
-
Last post by NHE